Adma Biologics (ADMA) Gross Margin Growth (5y) (2016 - 2025)
Adma Biologics (ADMA) Gross Margin Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10,076.00 |
| Sep 30, 2025 | -3,180.00 |
| Jun 30, 2025 | -3,362.00 |
| Mar 31, 2025 | 11,822.00 |
| Dec 31, 2024 | 26,883.00 |
| Sep 30, 2024 | -4,389.00 |
| Jun 30, 2024 | 10,347.00 |
| Mar 31, 2024 | 21,431.00 |
| Dec 31, 2023 | -221.00 |
| Sep 30, 2023 | -3,094.00 |
| Jun 30, 2023 | -3,463.00 |
| Mar 31, 2023 | -2,521.00 |
| Dec 31, 2022 | 2,682.00 |
| Sep 30, 2022 | -4,278.00 |
| Jun 30, 2022 | 3,785.00 |
| Mar 31, 2022 | -2,509.00 |
| Dec 31, 2021 | -6,052.00 |
| Sep 30, 2021 | -4,767.00 |
| Jun 30, 2021 | -4,865.00 |
| Mar 31, 2021 | -5,110.00 |